Delivery Order FA486121D0004-FA486125F0139
Award Date 3/16/25
Potential Completion Date 3/15/26
Potential Value $125K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Nellis AFB, NV, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded Genomic Health, Inc. a $145,066.32 firm fixed-price BPA call for Oncotype IQ genomic testing services, with an ultimate completion date of September 7, 2026. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in advanced genetic testing services focused on oncology diagnostics, particularly the Oncotype DX portfolio of gene expression assays. These tests support cancer screening, treatment selection, and disease monitoring across breast,...
- This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...
- This award is for a purchase order of $78,364.30 to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide breast cancer testing services to the Defense Health Agency. The contract has a firm fixed price pricing type and a completion date of September 30, 2016. Genomic Health is a for-profit organization that specializes in providing genomic cancer testing services to the federal government, including the Department of Veterans Affairs, Department of Defense, Air Force,...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
- This federal contract award is for ONCOTYPE TESTING services provided by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The $120,889 Firm Fixed Price contract was awarded by the Defense Health Agency, a component of the Department of Defense, on October 28, 2018. The contract has an ultimate completion date of October 28, 2019 and is a BPA Call, which allows the agency to order services on an as-needed basis. Genomic Health is a leading provider of genomic-based cancer testing...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of diagnostic testing supplies for cancer treatment. The potential value of the contract is $150,000.00, with a completion date of September 7, 2022. The contract was not set aside for any specific business type. Genomic Health has a history of providing cancer testing services, including its Oncotype DX portfolio of...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...